 | • レポートコード：20QY06-04276 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ランセットのグローバル市場について種類別（安全型ランセット、在宅介護型ランセット）、用途別（コレステロール検査、ブドウ糖検査、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ランセット市場の概要 ・世界の主要地域別ランセット市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のランセット市場規模2015-2026：種類別（安全型ランセット、在宅介護型ランセット） ・世界のランセット市場規模2015-2026：用途別（コレステロール検査、ブドウ糖検査、その他） ・ランセットの北米市場規模2015-2020 ・ランセットのヨーロッパ市場規模2015-2020 ・ランセットの中国市場規模2015-2020 ・ランセットの日本市場規模2015-2020 ・ランセットの東南アジア市場規模2015-2020 ・ランセットのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Lifescan、BD、Bayer、Abbott、B. Braun、ARKRAY、Terumo、I-SENS、Nipro、Omron、Infopia、AgaMatrix、Smiths Medical、Sarstedt、SANNUO、Yicheng、Yuwell、Greiner Bio One、Edan、Narang Medical） ・ランセットの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ランセットの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Lancets Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Lancets market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Lancets market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Lancets industry.
Based on our recent survey, we have several different scenarios about the Lancets YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2100.7 million in 2019. The market size of Lancets will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Lancets market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Lancets market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Lancets market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Lancets market. The report also includes nautical information, where it shows Lancets market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Lancets market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Lancets market.
The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.
Geographical Analysis:
Based on region, the global Lancets market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Lancets market are
Roche
Lifescan
BD
Bayer
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
Infopia
AgaMatrix
Smiths Medical
Sarstedt
SANNUO
Yicheng
Yuwell
Greiner Bio One
Edan
Narang Medical
Segment by Type
Safety Lancets
Homecare Lancets
Segment by Application
Cholesterol Tests
Glucose Tests
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Lancets market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Lancets market.
• The market share of the global Lancets market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Lancets market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Lancets market.
1 Lancets Market Overview
1.1 Lancets Product Scope
1.2 Lancets Segment by Type
1.2.1 Global Lancets Sales by Type (2020-2026)
1.2.2 Safety Lancets
1.2.3 Homecare Lancets
1.3 Lancets Segment by Application
1.3.1 Global Lancets Sales Comparison by Application (2020-2026)
1.3.2 Cholesterol Tests
1.3.3 Glucose Tests
1.3.4 Others
1.4 Lancets Market Estimates and Forecasts (2015-2026)
1.4.1 Global Lancets Sales Growth Rate (2015-2026)
1.4.2 Global Lancets Revenue and Growth Rate (2015-2026)
1.4.3 Global Lancets Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Lancets Industry Impact
1.5.1 How the Covid-19 is Affecting the Lancets Industry
1.5.1.1 Lancets Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Lancets Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Lancets Players to Combat Covid-19 Impact
2 Lancets Estimate and Forecast by Region
2.1 Global Lancets Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Lancets Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Lancets Sales Market Share by Region (2015-2020)
2.2.2 Global Lancets Revenue Market Share by Region (2015-2020)
2.3 Global Lancets Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Lancets Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Lancets Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Lancets Estimates and Projections (2015-2026)
2.4.2 Europe Lancets Estimates and Projections (2015-2026)
2.4.3 China Lancets Estimates and Projections (2015-2026)
2.4.4 Japan Lancets Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Lancets Estimates and Projections (2015-2026)
2.4.6 India Lancets Estimates and Projections (2015-2026)
3 Global Lancets Competition Landscape by Players
3.1 Global Top Lancets Players by Sales (2015-2020)
3.2 Global Top Lancets Players by Revenue (2015-2020)
3.3 Global Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lancets as of 2019)
3.4 Global Lancets Average Price by Company (2015-2020)
3.5 Manufacturers Lancets Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Lancets Players (Opinion Leaders)
4 Global Lancets Market Size by Type
4.1 Global Lancets Historic Market Review by Type (2015-2020)
4.1.1 Global Lancets Sales Market Share by Type (2015-2020)
4.1.2 Global Lancets Revenue Market Share by Type (2015-2020)
4.1.3 Global Lancets Price by Type (2014-2020)
4.2 Global Lancets Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Lancets Sales Forecast by Type (2021-2026)
4.2.2 Global Lancets Revenue Forecast by Type (2021-2026)
4.2.3 Global Lancets Price Forecast by Type (2021-2026)
5 Global Lancets Market Size by Application
5.1 Global Lancets Historic Market Review by Application (2015-2020)
5.1.1 Global Lancets Sales Market Share by Application (2015-2020)
5.1.2 Global Lancets Revenue Market Share by Application (2015-2020)
5.1.3 Global Lancets Price by Application (2015-2020)
5.2 Global Lancets Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Lancets Sales Forecast by Application (2021-2026)
5.2.2 Global Lancets Revenue Forecast by Application (2021-2026)
5.2.3 Global Lancets Price Forecast by Application (2021-2026)
3 North America Lancets Market Facts & Figures
3.2 North America Lancets Sales Market Share by Company (2015-2020)
3.3 North America Lancets Sales Market Share by Type (2015-2020)
3.4 North America Lancets Sales Market Share by Application (2015-2020)
4 Europe Lancets Market Facts & Figures
4.2 Europe Lancets Sales Market Share by Company (2015-2020)
4.3 Europe Lancets Sales Market Share by Type (2015-2020)
4.4 Europe Lancets Sales Market Share by Application (2015-2020)
5 China Lancets Market Facts & Figures
5.2 China Lancets Sales Market Share by Company (2015-2020)
5.3 China Lancets Sales Market Share by Type (2015-2020)
5.4 China Lancets Sales Market Share by Application (2015-2020)
6 Japan Lancets Market Facts & Figures
6.2 Japan Lancets Sales Market Share by Company (2015-2020)
6.3 Japan Lancets Sales Market Share by Type (2015-2020)
6.4 Japan Lancets Sales Market Share by Application (2015-2020)
7 Southeast Asia Lancets Market Facts & Figures
7.2 Southeast Asia Lancets Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Lancets Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Lancets Sales Market Share by Application (2015-2020)
8 India Lancets Market Facts & Figures
8.2 India Lancets Sales Market Share by Company (2015-2020)
8.3 India Lancets Sales Market Share by Type (2015-2020)
8.4 India Lancets Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Lancets Business
12.1 Roche
12.1.1 Roche Lancets Corporation Information
12.1.2 Roche Lancets Business Overview and Total Revenue
12.1.3 Roche Lancets Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Lancets Products Offered
12.1.5 Roche Recent Development
12.2 Lifescan
12.2.1 Lifescan Lancets Corporation Information
12.2.2 Lifescan Lancets Business Overview and Total Revenue
12.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Lifescan Lancets Products Offered
12.2.5 Lifescan Recent Development
12.3 BD
12.3.1 BD Lancets Corporation Information
12.3.2 BD Lancets Business Overview and Total Revenue
12.3.3 BD Lancets Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BD Lancets Products Offered
12.3.5 BD Recent Development
12.4 Bayer
12.4.1 Bayer Lancets Corporation Information
12.4.2 Bayer Lancets Business Overview and Total Revenue
12.4.3 Bayer Lancets Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer Lancets Products Offered
12.4.5 Bayer Recent Development
12.5 Abbott
12.5.1 Abbott Lancets Corporation Information
12.5.2 Abbott Lancets Business Overview and Total Revenue
12.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Abbott Lancets Products Offered
12.5.5 Abbott Recent Development
12.6 B. Braun
12.6.1 B. Braun Lancets Corporation Information
12.6.2 B. Braun Lancets Business Overview and Total Revenue
12.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2015-2020)
12.6.4 B. Braun Lancets Products Offered
12.6.5 B. Braun Recent Development
12.7 ARKRAY
12.7.1 ARKRAY Lancets Corporation Information
12.7.2 ARKRAY Lancets Business Overview and Total Revenue
12.7.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2015-2020)
12.7.4 ARKRAY Lancets Products Offered
12.7.5 ARKRAY Recent Development
12.8 Terumo
12.8.1 Terumo Lancets Corporation Information
12.8.2 Terumo Lancets Business Overview and Total Revenue
12.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Terumo Lancets Products Offered
12.8.5 Terumo Recent Development
12.9 I-SENS
12.9.1 I-SENS Lancets Corporation Information
12.9.2 I-SENS Lancets Business Overview and Total Revenue
12.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2015-2020)
12.9.4 I-SENS Lancets Products Offered
12.9.5 I-SENS Recent Development
12.10 Nipro
12.10.1 Nipro Lancets Corporation Information
12.10.2 Nipro Lancets Business Overview and Total Revenue
12.10.3 Nipro Lancets Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Nipro Lancets Products Offered
12.10.5 Nipro Recent Development
12.11 Omron
12.11.1 Omron Lancets Corporation Information
12.11.2 Omron Lancets Business Overview and Total Revenue
12.11.3 Omron Lancets Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Omron Lancets Products Offered
12.11.5 Omron Recent Development
12.12 Infopia
12.12.1 Infopia Lancets Corporation Information
12.12.2 Infopia Lancets Business Overview and Total Revenue
12.12.3 Infopia Lancets Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Infopia Lancets Products Offered
12.12.5 Infopia Recent Development
12.13 AgaMatrix
12.13.1 AgaMatrix Lancets Corporation Information
12.13.2 AgaMatrix Lancets Business Overview and Total Revenue
12.13.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2015-2020)
12.13.4 AgaMatrix Lancets Products Offered
12.13.5 AgaMatrix Recent Development
12.14 Smiths Medical
12.14.1 Smiths Medical Lancets Corporation Information
12.14.2 Smiths Medical Lancets Business Overview and Total Revenue
12.14.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Smiths Medical Lancets Products Offered
12.14.5 Smiths Medical Recent Development
12.15 Sarstedt
12.15.1 Sarstedt Lancets Corporation Information
12.15.2 Sarstedt Lancets Business Overview and Total Revenue
12.15.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Sarstedt Lancets Products Offered
12.15.5 Sarstedt Recent Development
12.16 SANNUO
12.16.1 SANNUO Lancets Corporation Information
12.16.2 SANNUO Lancets Business Overview and Total Revenue
12.16.3 SANNUO Lancets Sales, Revenue and Gross Margin (2015-2020)
12.16.4 SANNUO Lancets Products Offered
12.16.5 SANNUO Recent Development
12.17 Yicheng
12.17.1 Yicheng Lancets Corporation Information
12.17.2 Yicheng Lancets Business Overview and Total Revenue
12.17.3 Yicheng Lancets Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Yicheng Lancets Products Offered
12.17.5 Yicheng Recent Development
12.18 Yuwell
12.18.1 Yuwell Lancets Corporation Information
12.18.2 Yuwell Lancets Business Overview and Total Revenue
12.18.3 Yuwell Lancets Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Yuwell Lancets Products Offered
12.18.5 Yuwell Recent Development
12.19 Greiner Bio One
12.19.1 Greiner Bio One Lancets Corporation Information
12.19.2 Greiner Bio One Lancets Business Overview and Total Revenue
12.19.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Greiner Bio One Lancets Products Offered
12.19.5 Greiner Bio One Recent Development
12.20 Edan
12.20.1 Edan Lancets Corporation Information
12.20.2 Edan Lancets Business Overview and Total Revenue
12.20.3 Edan Lancets Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Edan Lancets Products Offered
12.20.5 Edan Recent Development
12.21 Narang Medical
12.21.1 Narang Medical Lancets Corporation Information
12.21.2 Narang Medical Lancets Business Overview and Total Revenue
12.21.3 Narang Medical Lancets Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Narang Medical Lancets Products Offered
12.21.5 Narang Medical Recent Development
13 Lancets Manufacturing Cost Analysis
13.1 Lancets Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Lancets
13.4 Lancets Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Lancets Distributors List
14.3 Lancets Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Lancets Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Lancets Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Lancets Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Lancets Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Lancets Players to Combat Covid-19 Impact
Table 8. Global Market Lancets Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Lancets Sales (M Units) by Region (2015-2020)
Table 10. Global Lancets Sales Market Share by Region (2015-2020)
Table 11. Global Lancets Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Lancets Revenue Share by Region (2015-2020)
Table 13. Global Lancets Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Lancets Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Lancets Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Lancets Revenue Share Forecast by Region (2021-2026)
Table 17. Global Lancets (M Units) of Key Companies (2015-2020)
Table 18. Global Lancets Sales Share by Company (2015-2020)
Table 19. Global Lancets Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Lancets Revenue Share by Company (2015-2020)
Table 21. Global Lancets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lancets as of 2019)
Table 22. Global Lancets Average Price (USD/K Units) of Key Company (2015-2020)
Table 23. Manufacturers Lancets Manufacturing Sites and Area Served
Table 24. Manufacturers Lancets Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Lancets Players
Table 27. Global Lancets Sales (M Units) by Type (2015-2020)
Table 28. Global Lancets Sales Share by Type (2015-2020)
Table 29. Global Lancets Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Lancets Price (M Units) by Type (2015-2020)
Table 31. Global Lancets Sales Share by Type (2021-2026)
Table 32. Global Lancets Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Lancets Revenue Share by Type (2021-2026)
Table 34. Global Lancets Price (M Units) by Type (2021-2026)
Table 35. Global Lancets Sales (M Units) by Application (2015-2020)
Table 36. Global Lancets Sales Share by Application (2015-2020)
Table 37. Global Lancets Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Lancets Price (M Units) by Application (2015-2020)
Table 39. Global Lancets Sales (M Units) by Application (2021-2026)
Table 40. Global Lancets Sales Share by Application (2021-2026)
Table 41. Global Lancets Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Lancets Revenue Share by Application (2021-2026)
Table 43. Global Lancets Price (M Units) by Application (2021-2026)
Table 44. United States Lancets Sales (M Units) by Company (2015-2020)
Table 45. United States Lancets Sales Market Share by Company (2015-2020)
Table 46. United States Lancets Sales (M Units) by Type (2015-2020)
Table 47. United States Lancets Sales Market Share by Type (2015-2020)
Table 48. United States Lancets Sales (M Units) by Application (2015-2020)
Table 49. United States Lancets Sales Market Share by Application (2015-2020)
Table 50. Europe Lancets Sales (M Units) by Company (2015-2020)
Table 51. Europe Lancets Sales Market Share by Company (2015-2020)
Table 52. Europe Lancets Sales (M Units) by Type (2015-2020)
Table 53. Europe Lancets Sales Market Share by Type (2015-2020)
Table 54. Europe Lancets Sales (M Units) by Application (2015-2020)
Table 55. Europe Lancets Sales Market Share by Type (2015-2020)
Table 56. China Lancets Sales (M Units) by Company (2015-2020)
Table 57. China Lancets Sales Market Share by Company (2015-2020)
Table 58. China Lancets Sales (M Units) by Type (2015-2020)
Table 59. China Lancets Sales Market Share by Type (2015-2020)
Table 60. China Lancets Sales (M Units) by Application (2015-2020)
Table 61. China Lancets Sales Market Share by Application (2015-2020)
Table 62. Japan Lancets Sales (M Units) by Company (2015-2020)
Table 63. Japan Lancets Sales Market Share by Company (2015-2020)
Table 64. Japan Lancets Sales (M Units) by Type (2015-2020)
Table 65. Japan Lancets Sales Market Share by Type (2015-2020)
Table 66. Japan Lancets Sales (M Units) by Application (2015-2020)
Table 67. Japan Lancets Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Lancets Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Lancets Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Lancets Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Lancets Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Lancets Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Lancets Sales Market Share by Application (2015-2020)
Table 74. India Lancets Sales (M Units) by Company (2015-2020)
Table 75. India Lancets Sales Market Share by Company (2015-2020)
Table 76. India Lancets Sales (M Units) by Type (2015-2020)
Table 77. India Lancets Sales Market Share by Type (2015-2020)
Table 78. India Lancets Sales (M Units) by Application (2015-2020)
Table 79. India Lancets Sales Market Share by Application (2015-2020)
Table 80. Roche Corporation Information
Table 81. Roche Description and Business Overview
Table 82. Roche Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 83. Roche Lancets Product
Table 84. Roche Recent Development
Table 85. Lifescan Corporation Information
Table 86. Lifescan Description and Business Overview
Table 87. Lifescan Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 88. Lifescan Lancets Product
Table 89. Lifescan Recent Development
Table 90. BD Corporation Information
Table 91. BD Description and Business Overview
Table 92. BD Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 93. BD Lancets Product
Table 94. BD Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 98. Bayer Lancets Product
Table 99. Bayer Recent Development
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 103. Abbott Lancets Product
Table 104. Abbott Recent Development
Table 105. B. Braun Corporation Information
Table 106. B. Braun Description and Business Overview
Table 107. B. Braun Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 108. B. Braun Lancets Product
Table 109. B. Braun Recent Development
Table 110. ARKRAY Corporation Information
Table 111. ARKRAY Description and Business Overview
Table 112. ARKRAY Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 113. ARKRAY Lancets Product
Table 114. ARKRAY Recent Development
Table 115. Terumo Corporation Information
Table 116. Terumo Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 117. Terumo Description and Business Overview
Table 118. Terumo Lancets Product
Table 119. Terumo Recent Development
Table 120. I-SENS Corporation Information
Table 121. I-SENS Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 122. I-SENS Description and Business Overview
Table 123. I-SENS Lancets Product
Table 124. I-SENS Recent Development
Table 125. Nipro Corporation Information
Table 126. Nipro Description and Business Overview
Table 127. Nipro Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 128. Nipro Lancets Product
Table 129. Nipro Recent Development
Table 130. Omron Corporation Information
Table 131. Omron Description and Business Overview
Table 132. Omron Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 133. Omron Lancets Product
Table 134. Omron Recent Development
Table 135. Infopia Corporation Information
Table 136. Infopia Description and Business Overview
Table 137. Infopia Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 138. Infopia Lancets Product
Table 139. Infopia Recent Development
Table 140. AgaMatrix Corporation Information
Table 141. AgaMatrix Description and Business Overview
Table 142. AgaMatrix Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 143. AgaMatrix Lancets Product
Table 144. AgaMatrix Recent Development
Table 145. Smiths Medical Corporation Information
Table 146. Smiths Medical Description and Business Overview
Table 147. Smiths Medical Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 148. Smiths Medical Lancets Product
Table 149. Smiths Medical Recent Development
Table 150. Sarstedt Corporation Information
Table 151. Sarstedt Description and Business Overview
Table 152. Sarstedt Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 153. Sarstedt Lancets Product
Table 154. Sarstedt Recent Development
Table 155. SANNUO Corporation Information
Table 156. SANNUO Description and Business Overview
Table 157. SANNUO Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 158. SANNUO Lancets Product
Table 159. SANNUO Recent Development
Table 160. Yicheng Corporation Information
Table 161. Yicheng Description and Business Overview
Table 162. Yicheng Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 163. Yicheng Lancets Product
Table 164. Yicheng Recent Development
Table 165. Yuwell Corporation Information
Table 166. Yuwell Description and Business Overview
Table 167. Yuwell Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 168. Yuwell Lancets Product
Table 169. Yuwell Recent Development
Table 170. Greiner Bio One Corporation Information
Table 171. Greiner Bio One Description and Business Overview
Table 172. Greiner Bio One Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 173. Greiner Bio One Lancets Product
Table 174. Greiner Bio One Recent Development
Table 175. Edan Corporation Information
Table 176. Edan Description and Business Overview
Table 177. Edan Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 178. Edan Lancets Product
Table 179. Edan Recent Development
Table . Narang Medical Corporation Information
Table . Narang Medical Description and Business Overview
Table . Narang Medical Lancets Sales (M Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table . Narang Medical Lancets Product
Table . Narang Medical Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Lancets Distributors List
Table 188. Lancets Customers List
Table 189. Market Key Trends
Table 190. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 191. Key Challenges
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Lancets Product Picture
Figure 2. Global Lancets Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Lancets Market Share by Application in 2020 & 2026
Figure 6. Cholesterol Tests Examples
Figure 7. Glucose Tests Examples
Figure 8. Others Examples
Figure 9. Global Lancets Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Lancets Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Lancets Price Trends Growth Rate (2015-2026) (USD/K Units)
Figure 12. Global Lancets Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Lancets Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Lancets Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Lancets Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Lancets Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Lancets Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Lancets Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Lancets Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Lancets Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Lancets Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Lancets Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Lancets Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Lancets Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Lancets Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Lancets Players Market Share by Revenue in Lancets 2015 & 2019
Figure 27. Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Lancets Revenue Share by Type (2015-2020)
Figure 29. Global Lancets Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Lancets Revenue Share by Application (2015-2020)
Figure 31. Global Lancets Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Lancets Sales Market Share by Type in 2019
Figure 33. United States Lancets Sales Market Share by Type in 2019
Figure 34. Europe Lancets Sales Market Share by Company in 2019
Figure 35. Europe Lancets Sales Market Share by Type in 2019
Figure 36. Europe Lancets Sales Market Share by Application in 2019
Figure 37. China Lancets Sales Market Share by Company in 2019
Figure 38. China Lancets Sales Market Share by Type in 2019
Figure 39. China Lancets Sales Market Share by Application in 2019
Figure 40. Japan Lancets Sales Market Share by Company in 2019
Figure 41. Japan Lancets Sales Market Share by Type in 2019
Figure 42. Japan Lancets Sales Market Share by Application in 2019
Figure 43. Southeast Asia Lancets Sales Market Share by Company in 2019
Figure 44. Southeast Asia Lancets Sales Market Share by Type in 2019
Figure 45. Southeast Asia Lancets Sales Market Share by Application in 2019
Figure 46. India Lancets Sales Market Share by Company in 2019
Figure 47. India Lancets Sales Market Share by Type in 2019
Figure 48. India Lancets Sales Market Share by Application in 2019
Figure 49. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Lifescan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. ARKRAY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Terumo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. I-SENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Nipro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Omron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Infopia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. AgaMatrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Smiths Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Sarstedt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. SANNUO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Yicheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Yuwell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Greiner Bio One Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Edan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Narang Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Key Raw Materials Price Trend
Figure 71. Manufacturing Cost Structure of Lancets
Figure 72. Manufacturing Process Analysis of Lancets
Figure 73. Lancets Industrial Chain Analysis
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Porter's Five Forces Analysis
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
糖尿病性穿刺器具の世界市場レポート2020 Diabetes is a global epidemic affecting an estimated 382 million people worldwide. The WHO projects that diabetes will be the 7th leading cause of death by 2030. An estimated 4 million people die annually from the complications associated with diabetes. Therefore, if the current trend associated wit…- 糖尿病デバイスの世界市場レポート2020 Diabetes Devices adopts the method of data collection and analysis of diabetes care for patients with diabetes make reasonable prediction and control of diseases. As living standards improve, an increasing obesity, the equipment has improved people's living habits, disease control effect, is becomin…
- 毛細血管採血デバイスの世界市場レポート2020 Blood Collection for sampling plays a vital role in the efficiency of patient treatment in hospitals, and diagnostic centers around the world. Blood sample collection procedure includes a chain of events, and every portion of this sequence is highly important to maintain high-quality clinical result…
- 肝炎ウイルス迅速検査の世界市場レポート2020 Market Analysis and Insights: Global Hepatitis Viruses Rapid Tests Market The global Hepatitis Viruses Rapid Tests market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Hepatitis Viruses Rapid Tests Scope and M…
- 迅速検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Rapid Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 12550 million by 2025, from USD 10650 million in 2019. The Rapid Tests market report …